MBX BIOSCIENCES INC. - COMMON STOCK

10,75

24-января-25 16:45:00

15 мин. задержка

Акции

-0,98

-8,35%

Сегодняшний диапазон

10,69 - 11,85

ISIN

N/A

Источник

NASDAQ

MBX Biosciences to Participate in Upcoming February Investor Conferences

23 янв 2025 08:00:00 Источник Nasdaq GlobeNewswire
MBX Biosciences Announces Positive Phase 1 Topline Results for MBX 1416 for the Treatment of Post-bariatric Hypoglycemia

07 янв 2025 07:00:00 Источник Nasdaq GlobeNewswire
MBX Biosciences to Participate in 43rd Annual J.P. Morgan Healthcare Conference

18 дек 2024 08:00:00 Источник Nasdaq GlobeNewswire
MBX Biosciences Announces MBX 2109 Phase 1 Study Results Published in The Journal of Clinical Endocrinology and Metabolism

02 дек 2024 08:00:00 Источник Nasdaq GlobeNewswire
MBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia

18 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire
MBX Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update

07 ноя 2024 08:00:01 Источник Nasdaq GlobeNewswire
MBX Biosciences to Participate in Upcoming November Investor Conferences

28 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire
MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting

30 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire
MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

16 сен 2024 16:05:00 Источник Nasdaq GlobeNewswire

<<
<
1
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.